NeoGenomics at SABCS 2026

Dec 8–11, 2026 San Antonio, TX ~11k attendees Website

NeoGenomics brings 2 presentations to SABCS 2026 in San Antonio, and exhibits at Booth 242. The cancer testing company presents on how triple-negative tumors evolve from early to metastatic stages and on real-world treatment, response and recurrence in early-stage disease.

OrganizationSABCS 2026 Attendance
NeoGenomics
Fort Myers, FL
Diagnostics
Cancer diagnostics company running CLIA-certified labs that offer a broad oncology testing menu to oncologists, pathologists, hospitals and drug developers.
Booth
Exhibiting at Booth 242
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Poster
Wed Dec 9
5–6:30pm
Stage specific molecular evolution across early-stage and metastatic triple-negative breast cancer
Exhibit Hall
Real-World Data and Real-World Evidence

Explore the full SABCS 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full SABCS 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at NeoGenomics

Tell us what you sell and we’ll find the people at NeoGenomics most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction